Mesenchymal stromal cell-derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction. - Wikidata - wikimedia - TriplyDB

Mesenchymal stromal cell-derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction.

Mesenchymal stromal cell-derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction.

http://www.wikidata.org/entity/Q45880435

about

Mesenchymal Stromal Cells Affect Disease Outcomes via Macrophage Polarization Mesenchymal stem cells in the treatment of inflammatory and autoimmune diseases in experimental animal models International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials.MSC-derived Extracellular Vesicles Attenuate Immune Responses in Two Autoimmune Murine Models: Type 1 Diabetes and Uveoretinitis.Separating graft-versus-leukemia from graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.Mesenchymal stem cell population derived from human pluripotent stem cells displays potent immunomodulatory and therapeutic properties Olf1/EBF associated zinc finger protein interfered with antinuclear antibody production in patients with systemic lupus erythematosus.The generation and maintenance of serum alloantibody.Comparative study on the therapeutic potential of neurally differentiated stem cells in a mouse model of multiple sclerosis.Secretion of immunoregulatory cytokines by mesenchymal stem cells.beta-Chemokine production by neural and glial progenitor cells is enhanced by HIV-1 Tat: effects on microglial migration.New concepts on the immune modulation mediated by mesenchymal stem cells.Bone marrow stromal cells as immunomodulators. A primer for dermatologists.Protective effects of mesenchymal stem cells with CXCR4 up-regulation in a rat renal transplantation model.Mesenchymal stem cells facilitate mixed hematopoietic chimerism induction and prevent onset of diabetes in nonobese diabetic mice Mesenchymal stem cells do not prevent antibody responses against human α-L-iduronidase when used to treat mucopolysaccharidosis type I.Regulation of Immunity via Multipotent Mesenchymal Stromal Cells.Immunomodulatory effect of mesenchymal stem cells on B cells.How mesenchymal stem cells interact with tissue immune responses.Inducible IL10(+) suppressor B cells inhibit CNS inflammation and T helper 17 polarization.CCR2-dependent recruitment of macrophages by tumor-educated mesenchymal stromal cells promotes tumor development and is mimicked by TNFα Mesenchymal stromal cells in transplantation rejection and tolerance.Human mesenchymal stromal/stem cells acquire immunostimulatory capacity upon cross-talk with natural killer cells and might improve the NK cell function of immunocompromised patients.Transcriptional profiling reveals intrinsic mRNA alterations in multipotent mesenchymal stromal cells isolated from bone marrow of newly-diagnosed type 1 diabetes patients CCL2 deficient mesenchymal stem cells fail to establish long-lasting contact with T cells and no longer ameliorate lupus symptoms.Galectin-9 is a suppressor of T and B cells and predicts the immune modulatory potential of mesenchymal stromal cell preparations Mesenchymal stem cells infected with Mycoplasma arginini secrete complement C3 to regulate immunoglobulin production in B lymphocytes.Approaches for immunological tolerance induction to stem cell-derived cell replacement therapies.Allogeneic mesenchymal stem cells: agents of immune modulation.Mesenchymal stromal cells for cardiovascular disease.Exploring the role of soluble factors associated with immune regulatory properties of mesenchymal stem cells.New insights on translational development of mesenchymal stromal cells for suppressor therapy.Mesenchymal stromal cells: a key player in 'innate tolerance'?Plasma cells in immunopathology: concepts and therapeutic strategies.Are stem cells a potential therapeutic tool in coeliac disease?Mesenchymal stem cells: a friend or foe in immune-mediated diseases.Mesenchymal stem cell-based therapy for nonhealing wounds: today and tomorrow.The Immunomodulatory and Therapeutic Effects of Mesenchymal Stromal Cells for Acute Lung Injury and Sepsis.The hemopoietic stem cell niche versus the microenvironment of the multiple myeloma-tumor initiating cell.Interleukin-36 receptor mediates the crosstalk between plasma cells and synovial fibroblasts.

P2860

Q26800098-6920BDE3-3E34-4E9F-B5E5-C6458C25A80B Q28085080-11C13255-60B7-4BAA-A6B9-E47BCBFCF313 Q30488740-47916D35-1803-4CAB-9FEE-02B2F7E7F7EA Q33659353-608E5D98-5015-4B7F-8EF8-D3993B0EEC79 Q33685495-F155CB96-753B-4942-BF64-0FF920D4F234 Q33861809-3C4F50E7-2122-4D00-9BB1-8369BD981272 Q33923396-C357A0BF-983E-4EA8-BAF2-FAF99E6F3860 Q34106158-4E6A839A-4045-45F8-A956-790B9F469A5D Q34238869-B9A90AEF-4508-4464-9526-3A2E59AAD665 Q34259098-F8809B03-6E45-4048-AF9E-DA06D179F924 Q34356438-55EEF916-3D26-4BC6-80F7-DA3780686BCD Q34513159-1E5A75AB-7E86-4A4D-B7DA-2CB161807621 Q34961598-8B5856A1-F6E6-4807-A587-B0E10201825F Q35080099-4666FD5A-0493-41A3-A394-8D98493A9CB6 Q35112634-ED124413-0C0D-442D-9B79-34E007B0E0A8 Q35124024-AC6F90CB-FAF8-40A3-849F-20086A7E10AD Q36025982-9A19D39C-AA0A-4A75-A8A6-E6FCD03BF14F Q36105639-1EE391C2-48CC-484A-A9C5-D31DF7420F4F Q36141205-FCB64F3D-1024-415D-A2BB-4C1A2C1C17DB Q36220700-5C07DAD0-1011-4065-86F9-93B8DBF67EB2 Q36456715-97D8FABC-4E43-4CD3-84B8-B70545942DBF Q36786630-423D9BFD-3D62-4D2E-8E7C-B897F58FA184 Q37077035-BC9D49FB-6D1B-4669-B443-8661B401A782 Q37089931-79793AF6-698A-44DE-A5C4-A561D7684930 Q37602101-A032D058-74FB-4562-A25B-8C13585E6215 Q37667547-171F921A-51F7-46EF-B1FF-6D637AA39D1B Q37726116-09540B1D-0454-4282-ABAA-B9965429F19D Q37742101-8DB99896-013F-4013-8796-BD5BFE9D02F9 Q37858927-54FF3AA2-7A1D-4B95-B4EC-206682FE715C Q37895928-64A09EA2-F823-4265-9D52-20A4F3B50786 Q37924625-D8B2FD7B-92BD-43DA-9FED-9B55AF9DECB8 Q37989396-FEE6FAD7-6D42-4890-AEC9-F2EF09540165 Q38026931-F1A2E944-08A5-4B1F-AD30-42F1B8F4FDBD Q38205130-2AB84E40-F6EC-4F65-A3FB-E8FF789BEF82 Q38289416-0B4612DA-4CF0-42DD-BE04-316EB3E53E28 Q38319943-1B4749B4-4DC4-41F6-9B69-5C6B1487DE1F Q38422834-7B6BE99B-C33B-49C6-9B75-178C0F5702D2 Q38442767-DBBEDC06-3696-477C-BE0C-297175B48C6D Q38569328-5B40ED64-78CC-44B6-A36B-0C9042B176BD Q38600649-7ACAC32D-E6B2-47F8-912A-E0B804E0D18A

P2860

Mesenchymal stromal cell-derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction.

http://www.wikidata.org/entity/Q45880435

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Mesenchymal stromal cell-deriv ...... activation and PAX5 induction.

@en

Mesenchymal stromal cell-deriv ...... activation and PAX5 induction.

@nl

type

label

Mesenchymal stromal cell-deriv ...... activation and PAX5 induction.

@en

Mesenchymal stromal cell-deriv ...... activation and PAX5 induction.

@nl

prefLabel

Mesenchymal stromal cell-deriv ...... activation and PAX5 induction.

@en

Mesenchymal stromal cell-deriv ...... activation and PAX5 induction.

@nl

P1433

Q45880435-4AD2DEC0-6C55-4A45-8817-C510CEAE8B8D

P1476

Q45880435-F51F053C-A47A-4151-A13D-A01C916C9AF7

P2093

Q45880435-0AE836DF-3834-48D2-B557-8085D8042B86

Q45880435-1CCB1700-5E89-4CB6-BEFB-DA5AD3C376E5

Q45880435-559F396A-2A9B-41A1-830B-C6E8FAE35850

Q45880435-682366A0-C944-4D25-923E-C0D1376E57CD

Q45880435-686FC73A-DDEF-4CA6-98D4-A9E678BC60A2

Q45880435-726EA975-A253-481A-A588-9A011ACF8F94

Q45880435-9263AA6F-9920-4D82-8787-9A06A19F1B99

Q45880435-ABB5389E-2400-4A71-9562-D7C6E4CAD5B2

Q45880435-B50BD3D3-CD8D-443A-A92C-C71E09DB00A1

Q45880435-DA919237-86B2-4C07-8583-FF56E01425EF

P304

Q45880435-DFD577A5-FCD8-46F3-A91D-B05531BD659E

P31

Q45880435-AE0D1B7E-EC4A-406C-8ABD-A22531B1F581

P356

Q45880435-1D0E9844-2E6E-4147-8D1D-A1EE4C3F0EF6

P407

Q45880435-0AB43EFC-5AAA-4627-92A0-71E59C053408

P433

Q45880435-D9E9FBB9-E683-4959-8499-09110D5A66C2

P478

Q45880435-7364323D-33CF-4C9B-BAE8-0AA3CDD05F1C

P50

Q45880435-C99B3320-B9D1-477C-9CF9-99B52A66D53D

P577

Q45880435-3ABD238F-B90C-480E-8E25-29FB56C3A32F

P5875

Q45880435-7B751EF7-9B30-4355-AE2A-70C43FE7A964

P698

Q45880435-56E0FC0B-8077-4A1D-A7BE-3984A847C172

P356

BLOOD-2008-07-166892

P1433

P1476

Mesenchymal stromal cell-deriv ...... activation and PAX5 induction.

@en

P2093

Borhane Annabi

http://www.w3.org/2001/XMLSchema#string

Elena Birman

http://www.w3.org/2001/XMLSchema#string

Jacques Galipeau

http://www.w3.org/2001/XMLSchema#string

Jeremy Hsieh

http://www.w3.org/2001/XMLSchema#string

Karen Doody

http://www.w3.org/2001/XMLSchema#string

Kathy Forner

http://www.w3.org/2001/XMLSchema#string

Marie-Noelle Boivin

http://www.w3.org/2001/XMLSchema#string

Mengyang Li

http://www.w3.org/2001/XMLSchema#string

Michel Tremblay

http://www.w3.org/2001/XMLSchema#string

Moutih Rafei

http://www.w3.org/2001/XMLSchema#string

P304

4991-4998

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2008-07-166892

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

112

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-09-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23277499

http://www.w3.org/2001/XMLSchema#string

P698

18812467

http://www.w3.org/2001/XMLSchema#string